Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
---|---|---|---|---|---|---|
|
body size and weight | Body weight, body length, body mass index. Aging study, 6mo, 12mo, 20mo. | inbred (32) | both | 26, 52, 87 wks | 2008 |
|
DXA | Body mass, fat mass, lean mass, bone mineral density and content, body area, bone area. Aging study, 6mo, 12mo, 20mo. | inbred (32) | both | 26, 52, 87 wks | 2008 |
|
study archive | Body, organ, fat pad weights, weight gain, litter size. | QTL population | both | 2-10wks | 2009 |
|
body weight
with high-fat high-sucrose diet |
Weekly. | DO population | both | 4-26wks | 2018 |
|
body weight
with high-fat diet |
8-29 wks of age. | BXD w/par (57) | m | 8-29 wks | 2016 |
|
body weight
with high-fat diet |
inbred w/CC8 | both | 8-21 wks | 2021 | |
|
body weight | Body weight | inbred (13) | m | 7-8wks | 2011 |
|
study archive | Plasma lipids. Cholesterol, triglycerides. | QTL population | both | 12-14wks | 2013 |
|
study archive | Bone morphology and strength, insulin-like growth factor 1. | QTL population | f | 16wks | 2001 |
|
body weight | Body weight and growth curve from 4wks to 26wks weighed monthly. | ILSXISS (97) | f | 6wks | 2005 |
|
body weight | Body weight | both | 8-20wks | 2021 | |
|
body weight
with influenza A (H5N1) virus |
Influenza A (H5N1) virus (several doses) vs. baseline. | inbred (23) | f | 6-9wks | 2011 |
|
body weight
with Theiler's murine encephalomyelitis virus |
Body weight | CC (5) | both | 4wks | 2017 |
|
study archive | Body, organ weights, litter size, abdominal fat, lipids, insulin, leptin. | QTL population | both | 3-6wks | 2009 |
|
study archive | Femur and vertebra morphology and strength. Monthly body weight 3 - 13 months. | QTL population | f | 14-56wks | 2012 |
|
body size and weight | Body weight and length. | inbred w/CC8 (72) | both | 10-13wks | 2009 |
|
DXA | Body mass, fat mass, lean mass, bone mineral density and content, bone area. | CC diallel w/par (62) | both | 8-16wks | 2012 |
|
body weight | Body weight | CC diallel w/par (62) | both | 8-16wks | 2012 |
|
body size and weight | Body weight, body length, tail length. | CC diallel w/par (62) | both | 7-15wks | 2011 |
|
body size and weight | Body weight, tail length. | CC pre w/par (367) | both | 7-15wks | 2011 |
|
body weight | Body weight | DO population w/par (9) | both | 12-16wks | 2013 |
|
study archive
with ethanol |
Sensitivity to ethanol. Baseline and ethanol. | QTL population | both | 9-34wks | 2012 |
|
body weight
with high-fat diet |
Body weight and growth curve from age 1wk to 22wks (pre-wean, post-wean, adult). High-fat diet (17wks) vs. control. | LGXSM w/par (19) | both | 12-16wks | 2004 |
|
body weight
with ethanol |
Body weight | inbred (8) | both | 8wks | 2003 |
|
body weight
with haloperidol |
Baseline vs. after haloperidol 60d implant. | inbred w/CC8 (27) | m | 9-28wks | 2012 |
|
body weight | Body weight | BXD w/par (55) | both | 10-16wks | 2018 |
|
body weight | Body weight | inbred (13) | both | 10wks | 2004 |
|
body weight | Body weight | BXD w/par (66) | both | 10wks | 2010 |
|
body weight | Pup body weight at day 3. | inbred (15) | f | 6-8wks | 2010 |
|
body weight | Pup body weight at day 3. | B6.A consomic w/par (22) | f | 6-8wks | 2010 |
|
body weight | Body weight | inbred (10) | both | 16wks | 2004 |
|
study archive | Urinalysis. Creatinine, microalbumin, body weight. | QTL population | m | 8-10wks | 2008 |
|
study archive | Sterility investigation. Sperm count, testes weight. | QTL population | m | 9wks | 2012 |
|
body weight | Body weight | inbred (14) | both | 9-12wks | 2003 |
|
body weight | Body weight | inbred (14) | both | 25wks | 2009 |
|
study archive | Colitis susceptibility, severity. Colon histopathology, body and spleen weight. | QTL population | both | 6wks | 2001 |
|
study archive | Blood pressure (tail cuff), kidney weight, body weight. | QTL population | m | 8wks | 2009 |
|
body weight
with influenza A (H1N1) virus |
Body weight | CC pre w/par (163) | f | 8-16wks | 2012 |
|
body size and weight | Body weight and length. | inbred w/CC8 (8) | both | 17-18wks | 2020 |
|
body weight
with West Nile virus |
Body weight | CC RIX (5) | m | 8-10wks | 2015 |
|
colony observation
with SARS-CoV |
Body weight loss and mortality. | CC RIX (117) | f | 8-10wks | 2021 |
|
study archive | Kidney morphology, renal cystic disease severity. | QTL population | f | 2wks | 2000 |
|
body weight | Body weight of newborns. | inbred (8) | both | postnatal | 2011 |
|
body weight | Body weight of newborns. | BXH (10) | both | postnatal | 2011 |
|
body weight | Daily body weight gain of cross-fostered pups. | inbred (31) | f | 14-18wks | 2012 |
|
body weight | Body weight | DO population | both | 8-60 wks | 2020 |
|
body weight | Body weight | inbred (14) | m | 8-10wks | 2010 |
|
body weight
with isoniazid |
Body weight. Isoniazid-treated vs. control. | inbred (34) | f | 8-10wks | 2011 |
|
body weight
with DB289 |
DB289-treated vs. control. | inbred (34) | f | 6-8wks | 2012 |
|
study archive
with high-fat diet |
Lipids, atherosclerosis lesions, parathyroid hormone after high-fat diet. | QTL population | f | 20wks | 2004 |
|
body weight | Body weight and growth curve from age 3wks to 10 wks, weighed weekly. | inbred (24) | both | 8wks | 2000 |
|
observation (SHIRPA) | Behavior, and neurosensory responses (SHIRPA protocol). | KOMP | both | 8-18wks | 2021 |
|
DXA | Body mass, fat mass, lean mass, bone mineral density and content, bone area. | KOMP | both | 8-18wks | 2021 |
|
observation (SHIRPA) | Behavior, and neurosensory responses (SHIRPA protocol). | KOMP | both | 66-81wks | 2021 |
|
DXA | Body mass, fat mass, lean mass, bone mineral density and content, bone area. | KOMP | both | 66-81wks | 2021 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight and growth curve from age 3wks to 16wks, weighed weekly. | inbred (10) | both | 3-16wks | 2014 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight | inbred (7) | both | 8-14wks | 2003 |
|
study archive | Characterization of high-muscle-mass mice. | QTL population | both | 3-10wks | 2011 |
|
study archive | Glucose, insulin, body and fat pad weights. | QTL population | m | 20-26wks | 2001 |
|
study archive
with cocaine |
Open field test. Locomotor, anxiety-related, circadian behavior. Baseline and after cocaine i.p. | QTL population | both | 10-14wks | 2014 |
|
body weight | Body weight | inbred w/CC8 (62) | both | 8-14wks | 2021 |
|
body size and weight | Body length measurements. | inbred w/CC8 (62) | both | 10-20 wks | 2021 |
|
study archive | Type 1 diabetes development study. | QTL population | f | 14-40wks | 2009 |
|
body weight | Body weight | CC pre (31) | both | 8-14wks | 2015 |
|
study archive
with western diet |
Lipids, atherosclerosis lesion histopathology. High-fat, western-style diet. | QTL population | f | 12wks | 2008 |
|
body weight | Body weight | inbred (41) | both | 8-9wks | 2010 |
|
body weight
with exercise |
Exercise (swim endurance training regimen) vs. control at weekly intervals for 5wks. | inbred (6) | m | 11-14wks | 2012 |
|
body weight | Body weight | CC (16) | both | 10wks | 2015 |
|
body weight | Body weight | inbred (34) | both | 8wks | 2012 |
|
body weight
with exercise |
Baseline vs. after exercise (access to running wheel). | CC pre w/par (184) | m | 10-12wks | 2011 |
|
body weight
with atenolol, isoproterenol |
Isoproterenol or atenolol vs. control. | inbred (23) | m | 10-12wks | 2009 |
|
body weight
with exercise |
Body weight before and after 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
body weight
with exercise |
Body weight before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
body weight
with ethanol |
Body weight | inbred (15) | m | 8-11wks | 2005 |
|
body weight | Body weight | CC (52) | m | 7-20wks | 2018 |
|
body weight
with high-fat diet and olanzapine |
Body weight and growth curve from age 8wks to 18wks weighed every 2wks. Olanzapine vs. control (both groups high-fat diet). | inbred w/CC8 (9) | f | 8-18wks | 2014 |
|
study archive | Kidney morphology. | QTL population | both | 1-2wks | 2005 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 12wks. | B6.A consomic w/par (24) | m | 5, 17 wks | 2008 |
|
body size and weight
with high-fat high-sucrose diet |
Body weight, size, and body mass index after 16wks on high-fat high-sucrose diet. | B6.A consomic w/par (24) | m | 5, 21 wks | 2015 |
|
body weight
with high-fat high-sucrose diet |
After 16 wks on high-fat high-sucrose diet. | inbred (2) | m | 21 wks | 2016 |
|
body weight
with high-fat high-sucrose diet |
High-fat high-sucrose diet for 14-15 wks | B6.A consomic w/par (3) | m | 4-19 wks | 2016 |
|
body size and weight
with high-fat high-sucrose diet |
Body length and body mass index after high-fat high-sucrose diet for 14-15 wks | B6.A consomic w/par (3) | m | 4-19 wks | 2016 |
|
body weight
with high-fat diet |
High-fat diet for 8wks. | inbred w/CC7 (43) | both | 5, 21 wks | 2003 |
|
body weight
with restricted diet |
Restricted diet vs. ad libitum diet. | ILSXISS (44) | both | max lifespan | 2010 |
|
body weight | Body weight | inbred (8) | m | 10-66wks | 2015 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 8wks. | inbred (44) | both | 15-19wks | 2000 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 8wks. | obesity mutants (8) | both | 15-19wks | 2000 |
|
body weight | Body weight | F1 Tcf7l2 (30) | both | 7-14wks | 2017 |
|
body weight
with methamphetamine |
Body weight | F1 Cacna1c (30) | both | 7-14wks | 2017 |
|
body weight | Body weight | F1 Tcf7l2 (30) | both | 7-14wks | 2017 |
|
body weight
with methamphetamine |
Body weight | F1 Cacna1c (30) | both | 7-14wks | 2017 |
|
study archive | Body weight of Gough Island mice. | QTL population | both | 1-16wks | 2015 |
|
study archive | Complete blood count measures on fetuses, newborns. | QTL population | both | fetus, newborn | 2004 |
|
body weight | Body weight | inbred (32) | m | 7-9wks | 2007 |
|
body size and weight | Body weight, body length, body mass index. | inbred (28) | m | 8, 12 wks | 2009 |
|
body size and weight | Body weight, body length, body mass index. | B6.129 and 129.B6 consomic w/par (9) | both | 26wks | 2015 |
|
study archive | Body weight (several ages), fat mass, body mass index, fat pad weights. | QTL population | m | 4-24wks | 2000 |
|
body weight
with exercise |
Exercise wheel group vs. control group. | inbred (12) | both | 8-15wks | 2010 |
|
study archive
with macronutrient diet option |
Caloric intake, glucose, body and fat pad weights. Macronutrient diet option. | QTL population | m | 8-13wks | 2002 |
|
body size and weight | Body weight, body length, tail length. | inbred RBRC (56) | both | 8, 12 wks | 2008 |
|
body size and weight | Body weight, body length, tail length. | wild-derived RBRC (33) | both | 8, 12 wks | 2008 |
|
body weight
with various diets |
Body weight at weaning and time of test. Comparison of 4 diets. | CC RIX (18) | f | 8-9 wks | 2018 |
|
body weight | Body weight | inbred (11) | both | 8-10wks | 2005 |
|
body weight
with high-fat diet |
At 8, 20 and 29 wks of age. | BXD w/par (36) | m | 8-29 wks | 2022 |
|
body weight
with influenza A (H1N1) virus |
Influenza A (H1N1) virus vs. baseline. Several timepoints. | inbred (9) | both | 10-12wks | 2009 |
|
body weight
with influenza A (H1N1) virus |
Influenza A (H1N1) virus vs. baseline. Several timepoints.. | BXD w/par (56) | f | 9-18wks | 2012 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus (several doses) vs. baseline. Several timepoints. | inbred w/CC8 (8) | both | 7-13wks | 2013 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus vs. controls. Several timepoints. | inbred w/CC8 (8) | f | 8-12wks | 2016 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus vs. controls. Several timepoints. | inbred w/CC8 (8) | f | 8-12wks | 2016 |
|
body weight | Body weight | inbred (7) | both | 9-18wks | 2000 |
|
body weight | Body weight | inbred (16) | both | 7-9wks | 2001 |
|
body weight
with high-fat diet |
High-fat diet for 4wks vs. control. | inbred (10) | both | 10-13wks | 2008 |
|
body weight | Body weight | CC (12) | m | 15-33wks | 2020 |
|
body weight | Body weight | CC RIX (28) | m | 7-44wks | 2020 |
|
body weight | Body weight | DO population | m | 12-15wks | 2020 |
|
study archive | Open field test, forced swim test, defensive burying task. | QTL population | both | 11-17wks | 2004 |
|
study archive
with high-fat diet |
Body size, weight, fat pad weights after high-fat diet. | QTL population | both | 24wks | 2006 |
|
study archive | Lipids. Cholesterol, triglycerides, body weight. | QTL population | both | 8-10wks | 2006 |
|
study archive | Blood pressure (tail cuff), heart weight, body weight. | QTL population | m | 10wks | 2002 |
|
body weight
with selenium |
Body weight curve 3 to 12 wks, control group. | inbred w/CC8 (8) | m | 3-14wks | 2018 |
|
body size and weight | Body weight, body length, body mass index. | B6.PWD consomic w/par (28) | both | 16wks | 2006 |
|
DXA | Body mass, fat mass, lean mass, bone mineral density and content. | B6.PWD consomic w/par (28) | both | 16wks | 2006 |
|
body weight
with cocaine |
Body weight | inbred (45) | m | 8-11wks | 2015 |
|
body weight | Body weight | inbred (28) | m | 4-12wks | 2001 |
|
body weight | Body weight | inbred w/CC7 (40) | both | 9-15wks | 2002 |
|
study archive | Brain weight, body weight. | QTL population | both | 2005 | |
|
body weight | Body weight | ILSXISS (43) | both | 8-23wks | 2015 |
|
body weight | Body weight | inbred (21) | both | 6-8wks | 2009 |
|
body weight | Body weight | inbred w/CC7 (40) | both | 5-6wks | 2002 |
|
study archive
with high-fat diet |
Liver weight, gallbladder and gallstone histopathology. | QTL population | both | 18-20wks | 2002 |
|
study archive
with high-fat diet |
Lipids (plasma), liver weight, gallbladder and gallstone histopathology. | QTL population | both | 6-16wks | 2003 |
|
study archive
with high-fat diet |
Lipids (plasma), liver weight, gallbladder and gallstone histopathology. | QTL population | both | 2005 | |
|
body weight | Body weight | CC RIX (73) | both | 7-13wks | 2020 |
|
body weight
with arsenic |
Baseline, then after iAs exposure for 26 wks | DO population | m | 4-34 wks | 2022 |
|
MRI
with arsenic |
Fat and lean tissue mass at baseline, and 12 and 24 wks after iAs exposure | DO population | m | 4-34 wks | 2022 |
|
study archive | Body weight (several timepoints) and liver weight. | QTL population | both | 2-12wks | 2007 |
|
body weight | Aging study, 6mo, 12mo, and 18mo. | inbred (33) | both | 26, 52, 78 wks | 2007 |
|
study archive
with western diet |
Atherosclerosis and glucose homeostasis. Lesions, lipids, glucose, insulin. High-fat, western-style diet. | QTL population | f | <6-18wks | 2012 |
|
body weight | inbred (30) | both | 7-15 wks | 2020 |